GLENN CUNNINGHAM to Enzyme Inhibitors
This is a "connection" page, showing publications GLENN CUNNINGHAM has written about Enzyme Inhibitors.
Connection Strength
0.525
-
Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer. J Urol. 2007 Oct; 178(4 Pt 1):1521-7.
Score: 0.229
-
Lovastatin-induced apoptosis in prostate stromal cells. J Clin Endocrinol Metab. 1997 May; 82(5):1434-9.
Score: 0.112
-
Anti-androgen effects of the aromatase inhibitor, atamestane. J Androl. 1995 Mar-Apr; 16(2):100-7.
Score: 0.096
-
Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004 May; 89(5):2179-84.
Score: 0.045
-
Induction of apoptosis in BPH stromal cells by adenoviral-mediated overexpression of caspase-7. J Urol. 2000 Aug; 164(2):518-25.
Score: 0.035
-
Caspase-7 is activated during lovastatin-induced apoptosis of the prostate cancer cell line LNCaP. Cancer Res. 1998 Jan 01; 58(1):76-83.
Score: 0.007